Literature DB >> 9543386

C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

C Y Peng1, P R Graves, S Ogg, R S Thoma, M J Byrnes, Z Wu, M T Stephenson, H Piwnica-Worms.   

Abstract

Cdc25C is a dual-specificity protein kinase that controls entry into mitosis by dephosphorylating Cdc2 on both threonine 14 and tyrosine 15. Cdc25C is phosphorylated on serine 216 throughout interphase but not during mitosis. Serine 216 phosphorylation mediates the binding of 14-3-3 protein to Cdc25C, and Cdc25C/14-3-3 complexes are present throughout interphase but not during mitosis. Here we report the cloning of a human kinase denoted C-TAK1 (for Cdc twenty-five C associated protein kinase) that phosphorylates Cdc25C on serine 216 in vitro. C-TAK1 is ubiquitously expressed in human tissues and cell lines and is distinct from the DNA damage checkpoint kinase Chk1, shown previously to phosphorylate Cdc25C on serine 216. Cotransfection of Cdc25C with C-TAK1 resulted in enhanced phosphorylation of Cdc25C on serine 216. In addition, a physical interaction between C-TAK1 and Cdc25C was observed upon transient overexpression in COS-7 cells. Finally, coproduction of Cdc25C and C-TAK1 in bacteria resulted in the stoichiometric phosphorylation of Cdc25C on serine 216 and facilitated 14-3-3 protein binding in vitro. Taken together, these results suggest that one function of C-TAK1 may be to regulate the interactions between Cdc25C and 14-3-3 in vivo by phosphorylating Cdc25C on serine 216.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543386

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  74 in total

1.  DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding.

Authors:  Y Zeng; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

3.  A quantitative analysis of the kinetics of the G(2) DNA damage checkpoint system.

Authors:  B D Aguda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 4.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

5.  Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage.

Authors:  L Chen; T H Liu; N C Walworth
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

Review 6.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

7.  Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.

Authors:  Hui Tian; Alexander T Faje; Siu Lan Lee; Timothy J Jorgensen
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

8.  Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site.

Authors:  S N Dalal; C M Schweitzer; J Gan; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

9.  Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip.

Authors:  Shen-Hua Xu; Li-Juan Qian; Han-Zhou Mou; Chi-Hong Zhu; Xing-Ming Zhou; Xiang-Lin Liu; Yong Chen; Wen-Yu Bao
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

10.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.